|This article needs additional citations for verification. (February 2008) (Learn how and when to remove this template message)|
|ICD-9-CM||43.89, 45.51 45.91|
The duodenal switch (DS) procedure, also known as biliopancreatic diversion with duodenal switch (BPD-DS) or gastric reduction duodenal switch (GRDS), is a weight loss surgery procedure that is composed of a restrictive and a malabsorptive aspect.
The malabsorptive portion of the surgery reroutes a lengthy portion of the small intestine, creating two separate pathways and one common channel. The shorter of the two pathways, the digestive loop, takes food from the stomach to the common channel. The much longer pathway, the biliopancreatic loop, carries bile from the liver to the common channel.
The common channel is the portion of small intestine, usually 75-150 centimeters long, in which the contents of the digestive path mix with the bile from the biliopancreatic loop before emptying into the large intestine. The objective of this arrangement is to reduce the amount of time the body has to capture calories from food in the small intestine and to selectively limit the absorption of fat. As a result, following surgery, these patients only absorb approximately 20% of the fat they intake.
Comparison to other surgeries
The primary advantage of duodenal switch (DS) surgery is that its combination of moderate intake restriction with substantial calorie malabsorption results in a higher percentage of excess weight loss versus a purely restrictive gastric bypass for all individuals  In a Systemic Meta Analysis of the weight loss surgical procedures Buckwald et al. Type 2 diabetics have had a 98% "cure" (i.e. became euglycemic) almost immediately following surgery which is due to the metabolic effect from the intestine switch. The results are so favorable that some surgeons in Europe are performing the "switch" or intestinal surgery on non-obese patients for the benefits of curing the diabetes. Novel operations are geared toward the treatment of diabetes and not necessarily to induce weight loss. Among the most prominent of these operations are the duodenal-jejunal bypass and ileal transposition where duodenal switch is a part of the operation.
The following observations were reported on the resolution of obesity related comorbidities following the duodenal switch: type 2 diabetes 99%, hyperlipidemia 99%, sleep apnea 92%, and hypertension 83%.
Because the pyloric valve between the stomach and small intestine is preserved, people who have undergone the DS do not experience the dumping syndrome common with people who've undergone the Roux-en-Y gastric bypass surgery (RNY). Much of the production of the hunger hormone, ghrelin, is removed with the greater curvature of the stomach.
The summarized data can be found on a poster: comparative poster
Diet following the DS is more normal and better tolerated than with other surgeries.
The malabsorptive component of the DS is fully reversible as no small intestine is actually removed, only re-routed.
The malabsorptive element of the DS requires that those who undergo the procedure take vitamin and mineral supplements above and beyond that of the normal population, as do patients having the RNY surgery. Commonly prescribed supplements include a daily multivitamin, calcium citrate, and the fat-soluble vitamins A, D, E and K.
Because gallstones are a common complication of rapid weight loss following any type of weight loss surgery, some surgeons may remove the gall bladder as a preventative measure during the DS or the RNY. Others prefer to prescribe medication to reduce the risk of post-operative gallstones.
Like RNY patients, DS patients require lifelong and extensive blood tests to check for deficiencies in life critical vitamins and minerals. Without proper follow up tests and lifetime supplementation RNY and DS patients can become ill. This follow-up care is non-optional and must continue for as long as the patient lives.
The restrictive portion of the DS is not reversible, since part of the stomach is removed. However, the stomach in all DS patients does expand over time, and while it will never reach the same size as the natural stomach in most patients, some stretching does occur.
All surgical procedures involve a degree of risk however this must be balanced against the significant risks associated with severe obesity.
Some of the surgical risks or complications for this procedure are: perforation involving small bowel, duodenum, or stomach causing a leak, infection, abscess, deep vein thrombosis (blood clot), and pulmonary emboli (blood clot traveling to the lungs).
Longer term risks include the possibility of vitamin and mineral deficiency, hernia and bowel obstruction. There is little information as to the longer-term risks (greater than 15 years), as this procedure was very rarely performed prior to the year 2000.
Malnutrition is an uncommon and preventable risk after duodenal switch.
- BMI of 40 or over
- BMI of 35 or over with obesity-related illnesses such as:
- An understanding of the operation and lifestyle changes necessary following the surgery.
Compared with the other three generally accepted bariatric surgery procedures (gastric bypass, gastric banding and gastric sleeve), duodenal switch surgery is the most expensive procedure to perform due to its more complicated nature and longer operating times. Because it is more complicated and is performed less often than the other common procedures (lower demand), it is also performed by a relatively small percentage of surgeons which further drives up the price due to lack of competition.
Patients without insurance (also called "self-pay" patients by most bariatric practices) can expect to pay an average of about $27,000 in the United States, although this varies widely across states and clinics. For example, surgical practices in the least expensive state (New Jersey) average about $24,000 while practices in the most expensive state (Nebraska) charge about $32,500. This surgery is also performed by some surgeons in Mexico at a much lower cost than in the United States.
- "Coding for Obesity". Retrieved 2007-10-14.
- L. Biertho et al. BPL-DS indicated for patient with BMI<50. SOARD 6(2010)508-515.
- Bariatric Surgery, A systematic Review and Meta-Analysis JAMA, October 13, 2004-Vol (292) (14) 1724-1728
- Hess DS, Hess DW, Oakley RS (2005). "The Biliopancreatic Diversion with the Duodenal Switch: Results Beyond 10 Years". Obesity Surgery. 15 (3): 408–16. doi:10.1381/0960892053576695. PMID 15826478.
- Rubino F, Moo T, Rosen DJ, Dakin GF, Pomp A (2009). "Diabetes Surgery: A New Approach to an Old Disease". Diabetes Care. 32(Suppl 2) (suppl_2): S368–S372. doi:10.2337/dc09-S341. PMC . PMID 19875583.
- Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K (2004). "Bariatric surgery: a systematic review and meta-analysis". JAMA. 292 (14): 1724–37. doi:10.1001/jama.292.14.1724. PMID 15479938.
- Baltasar A, Bou R, Bengochea M, Arlandis F, Escriva C, Mir J, Martinez R, Perez N (2001). "Duodenal switch: an effective therapy for morbid obesity--intermediate results". Obesity Surgery. 11 (1): 54–8. doi:10.1381/096089201321454114. PMID 11361169.
- Aasheim ET, Björkman S, Søvik TT, Engström M, Hanvold SE, Mala T, Olbers T, Bøhmer T (2009). "Vitamin status after bariatric surgery: a randomized study of gastric bypass and duodenal switch.". American Journal of Clinical Nutrition. 90 (1): 15–22. doi:10.3945/ajcn.2009.27583. PMID 19439456.
- Marceau P, Biron S, Hould FS, Lebel S, Marceau S, Lescelleur O, Biertho L, Simard S (2007). "Duodenal Switch: Long-Term Results". Obesity Surgery. 17 (11): 1421–30. doi:10.1007/s11695-008-9435-9. PMID 18219767.
- Weight-control Information Network, National Institutes of Health. Gastrointestinal Surgery for Severe Obesity
- Quinlan, J, Duodenal Switch Surgery (DS): Complete Patient Guide, Bariatric Surgery Source, retrieved 10 November 2014